BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32916984)

  • 1. Pregnancy in Patients with Type One Diabetes Mellitus Treated with Continuous Subcutaneous Insulin Infusion-Preconception Basal Insulin Dose as a Potential Risk Factor for Fetal Overgrowth?
    Lekšić G; Baretić M; Ivanišević M; Jurišić-Eržen D
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32916984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M
    Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
    Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
    Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
    Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
    Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.
    Neff KJ; Forde R; Gavin C; Byrne MM; Firth RG; Daly S; McAuliffe FM; Foley M; Coffey M; Coulter-Smith S; Kinsley BT
    Ir J Med Sci; 2014 Sep; 183(3):397-403. PubMed ID: 24142539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus.
    Mantaj U; Gutaj P; Ozegowska K; Zawiejska A; Wroblewska-Seniuk K; Olejniczak D; Wender-Ozegowska E
    Ginekol Pol; 2019; 90(3):154-160. PubMed ID: 30950005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin for the Management of Type 1 Diabetes Mellitus in Pregnancy: Association with Neonatal Chemical Hypoglycemia.
    Sargent JA; Roeder HA; Ward KK; Moore TR; Ramos GA
    Am J Perinatol; 2015 Dec; 32(14):1324-30. PubMed ID: 26461928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
    Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
    Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in diabetes management: have pregnancy outcomes in women with type 1 diabetes changed in the last decades?
    Citro F; Bianchi C; Nicolì F; Aragona M; Marchetti P; Di Cianni G; Bertolotto A
    Diabetes Res Clin Pract; 2023 Nov; 205():110979. PubMed ID: 37890701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J; West HM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P; Juuti M; Walle T; Laatikainen T
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Postpartum Insulin Requirements for Patients with Well-Controlled Type 1 Diabetes.
    Roeder HA; Moore TR; Ramos GA
    Am J Perinatol; 2016 Jun; 33(7):683-7. PubMed ID: 26862721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.
    Ladfors L; Shaat N; Wiberg N; Katasarou A; Berntorp K; Kristensen K
    PLoS One; 2017; 12(11):e0187917. PubMed ID: 29121112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for large-for-gestational age infants in pregnant women with type 1 diabetes.
    Morrens A; Verhaeghe J; Vanhole C; Devlieger R; Mathieu C; Benhalima K
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):162. PubMed ID: 27421257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
    Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
    J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.